Unbiased peptoid combinatorial cell screen identifies plectin protein as a potential biomarker for lung cancer stem cells

Aaron C. Raymond, Boning Gao, Luc Girard, John D. Minna, D. Gomika Udugamasooriya

Research output: Contribution to journalArticle

Abstract

Tumors often contain a small subset of drug-resisting, self-renewing, and highly metastatic cells called tumor initiating cells or cancer stem cells (CSCs). To develop new approaches to detecting and targeting lung cancer CSCs, we applied an “unbiased” peptoid combinatorial cell screen to identify highly specific ligands that bind a CSC subpopulation of non-small cell lung cancer cells (defined by Aldefluor positivity), but not the remaining aldefluor negative cancer cells from the same preclinical model. One of the ‘hit’ peptoids bound to plectin, a structural protein, predominantly expressed intracellularly, but whose localization on the cell surface is linked to tumor invasion and metastasis. Our studies show both genotypic and phenotypic correlations between plectin and lung CSCs, as well as association of high plectin mRNA expression with poor patient survival in lung adenocarcinoma, potentially identifying plectin as a biomarker for lung CSCs.

Original languageEnglish (US)
Article number14954
JournalScientific reports
Volume9
Issue number1
DOIs
StatePublished - Dec 1 2019

Fingerprint

Plectin
Peptoids
Neoplastic Stem Cells
Lung Neoplasms
Biomarkers
Proteins
Neoplasms
Non-Small Cell Lung Carcinoma
Neoplasm Metastasis
Ligands
Messenger RNA
Survival

ASJC Scopus subject areas

  • General

Cite this

Unbiased peptoid combinatorial cell screen identifies plectin protein as a potential biomarker for lung cancer stem cells. / Raymond, Aaron C.; Gao, Boning; Girard, Luc; Minna, John D.; Gomika Udugamasooriya, D.

In: Scientific reports, Vol. 9, No. 1, 14954, 01.12.2019.

Research output: Contribution to journalArticle

@article{7cc4359e148e4b9e972c291e90c8af2c,
title = "Unbiased peptoid combinatorial cell screen identifies plectin protein as a potential biomarker for lung cancer stem cells",
abstract = "Tumors often contain a small subset of drug-resisting, self-renewing, and highly metastatic cells called tumor initiating cells or cancer stem cells (CSCs). To develop new approaches to detecting and targeting lung cancer CSCs, we applied an “unbiased” peptoid combinatorial cell screen to identify highly specific ligands that bind a CSC subpopulation of non-small cell lung cancer cells (defined by Aldefluor positivity), but not the remaining aldefluor negative cancer cells from the same preclinical model. One of the ‘hit’ peptoids bound to plectin, a structural protein, predominantly expressed intracellularly, but whose localization on the cell surface is linked to tumor invasion and metastasis. Our studies show both genotypic and phenotypic correlations between plectin and lung CSCs, as well as association of high plectin mRNA expression with poor patient survival in lung adenocarcinoma, potentially identifying plectin as a biomarker for lung CSCs.",
author = "Raymond, {Aaron C.} and Boning Gao and Luc Girard and Minna, {John D.} and {Gomika Udugamasooriya}, D.",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41598-019-51004-3",
language = "English (US)",
volume = "9",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Unbiased peptoid combinatorial cell screen identifies plectin protein as a potential biomarker for lung cancer stem cells

AU - Raymond, Aaron C.

AU - Gao, Boning

AU - Girard, Luc

AU - Minna, John D.

AU - Gomika Udugamasooriya, D.

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Tumors often contain a small subset of drug-resisting, self-renewing, and highly metastatic cells called tumor initiating cells or cancer stem cells (CSCs). To develop new approaches to detecting and targeting lung cancer CSCs, we applied an “unbiased” peptoid combinatorial cell screen to identify highly specific ligands that bind a CSC subpopulation of non-small cell lung cancer cells (defined by Aldefluor positivity), but not the remaining aldefluor negative cancer cells from the same preclinical model. One of the ‘hit’ peptoids bound to plectin, a structural protein, predominantly expressed intracellularly, but whose localization on the cell surface is linked to tumor invasion and metastasis. Our studies show both genotypic and phenotypic correlations between plectin and lung CSCs, as well as association of high plectin mRNA expression with poor patient survival in lung adenocarcinoma, potentially identifying plectin as a biomarker for lung CSCs.

AB - Tumors often contain a small subset of drug-resisting, self-renewing, and highly metastatic cells called tumor initiating cells or cancer stem cells (CSCs). To develop new approaches to detecting and targeting lung cancer CSCs, we applied an “unbiased” peptoid combinatorial cell screen to identify highly specific ligands that bind a CSC subpopulation of non-small cell lung cancer cells (defined by Aldefluor positivity), but not the remaining aldefluor negative cancer cells from the same preclinical model. One of the ‘hit’ peptoids bound to plectin, a structural protein, predominantly expressed intracellularly, but whose localization on the cell surface is linked to tumor invasion and metastasis. Our studies show both genotypic and phenotypic correlations between plectin and lung CSCs, as well as association of high plectin mRNA expression with poor patient survival in lung adenocarcinoma, potentially identifying plectin as a biomarker for lung CSCs.

UR - http://www.scopus.com/inward/record.url?scp=85073598777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073598777&partnerID=8YFLogxK

U2 - 10.1038/s41598-019-51004-3

DO - 10.1038/s41598-019-51004-3

M3 - Article

C2 - 31628412

AN - SCOPUS:85073598777

VL - 9

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 14954

ER -